Real-World Outcomes with Panobinostat in Patients with Relapsed/Refractory Multiple Myeloma

被引：0
|
作者：
Biran, Noa [1 ]
Vesole, David H. [1 ]
Zhang, Shijia [2 ]
Richter, Joshua R. [1 ]
Kuo, Yen-Hong [3 ]
Schmidt, Linda [1 ]
McBride, Laura [1 ]
Anand, Palka [1 ]
Ivanovski, Kristin [1 ]
Pierre, Amy
Kumka, Susan [1 ]
Cuccurullo, Carmela [1 ]
Siegel, David S. [1 ]
机构：
[1] Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA
[2] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ USA
[3] Jersey Shore Univ Med Ctr, Dept Res, Neptune, NJ USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5685.5685
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5685
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Current Real-World Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma
    Willson, Jenny
    Bruno, Amanda
    Opalinska, Joanna
    Nelson, Jeannene
    Lunacsek, Orsolya
    Stafkey-Mailey, Dana
    Willey, Joanne
    BLOOD, 2018, 132
  • [2] Real-world outcomes with panobinostat in patients with penta- and quad-refractory multiple myeloma.
    Biran, Noa
    Vesole, David H.
    Zhang, Shijia
    Richter, Joshua Ryan
    Kuo, Yen Hong
    Schmidt, Linda
    McBride, Laura
    Anand, Palka
    Ivanovski, Kristin
    Pierre, Amy
    Kumka, Susan
    Cucurrulo, Carmella
    Siegel, David
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma
    Bruno, Amanda S.
    Willson, Jenny L.
    Opalinska, Joanna M.
    Nelson, Jeanenne J.
    Lunacsek, Orsolya E.
    Stafkey-Mailey, Dana R.
    Willey, Joanne P.
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (09) : 1017 - 1025
  • [4] Current real-world treatment patterns and outcomes in patients with relapsed/refractory multiple myeloma.
    Willson, Jenny
    Bruno, Amanda
    Opalinska, Joanna
    Nelson, Jeanenne Joy
    Lunacsek, Orsolya
    Stafkey-Mailey, Dana
    Willey, Joanne P.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Real-World Outcomes for Standard-ofCare Treatments in Patients with Relapsed/Refractory Multiple Myeloma
    Delforge, Michael
    Vekemans, Marie-Christiane
    Anguille, Sebastien
    Depaus, Julien
    Meuleman, Nathalie
    Van de Velde, Ann
    Van de Broek, Isabelle
    Strens, Danielle
    Van Hoorenbeeck, Sandra
    Moorkens, Evelien J.
    Diels, Jorks
    Ghilotti, Francesca
    Dalhuisen, Sander
    Vandervennet, Sophie
    BLOOD, 2021, 138
  • [6] Real-World Treatment of Patients With Relapsed/Refractory Myeloma
    Ntanasis-Stathopoulos, Ioannis
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (06): : 379 - 385
  • [7] Real-world outcomes of daratumumab monotherapy in relapsed/refractory myeloma
    Maouche, N.
    Leary, H.
    Collings, F.
    Tseu, B.
    Djebbari, F.
    Vallance, G.
    Ramasamy, K.
    Kothari, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 125 - 125
  • [8] Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma
    Huang, Shang-Yi
    Chen, Tsai-Yun
    Kuo, Ching-Yuan
    Chen, Yeu-Chin
    Lin, Sheng-Fung
    Chang, Ming-Chih
    Lv, Xinzhu
    Yang, Betty
    Chang, Cheng-Shyong
    ONCOLOGY REVIEWS, 2019, 13 (01) : 15 - 22
  • [9] Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma, a Real-World Experience
    Hultcrantz, Malin
    Orozco, Jennifer
    Peterson, Tim J.
    Derkach, Andriy
    Hassoun, Hani
    Korde, Neha
    Lu, Sydney X.
    Mailankody, Sham
    Patel, Dhwani
    Shah, Urvi A.
    Tan, Carlyn
    Maclachlan, Kylee H.
    Chung, David J.
    Landau, Heather J.
    Shah, Gunjan L.
    Lahoud, Oscar B.
    Scordo, Michael
    Landgren, Ola
    Giralt, Sergio
    Lesokhin, Alexander
    BLOOD, 2021, 138
  • [10] Real-World Practice Patterns with Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma
    Harvey, R. Donald
    Cong, Ze
    Werther, Winifred
    Lethen, Jan L.
    Lonial, Sagar
    BLOOD, 2014, 124 (21)
12345